Exact Sciences Corp (NAS:EXAS)
$ 52.78 -0.74 (-1.38%) Market Cap: 9.74 Bil Enterprise Value: 11.78 Bil PE Ratio: 0 PB Ratio: 3.10 GF Score: 78/100

Exact Sciences Corp at Bank of America Merrill Lynch Health Care Conference Transcript

May 15, 2019 / 08:00PM GMT
Release Date Price: $95.37 (+3.66%)
Ivy Ma
BofA Merrill Lynch, Research Division - Associate

Hello, everyone. Welcome to day 2 of our health care conference. My name is Ivy Ma. I work on the tools and diagnostics team here at BofA. And today, we are very glad to have the Exact Sciences team join us. Well, before we go into that, I wanted to send some greetings from my senior analyst, Derik De Bruin, who's recovering from surgery and couldn't made it -- couldn't make it to the conference this time. But he's here in spirit and is following the webcast.

Well, on to more important things. Very glad to have Exact join us this year. We have Kevin, CEO; and CFO, Jeff. Very glad to have you guys here. And I know Kevin wanted to start with presentation, and we'll then take some questions.

Kevin T. Conroy
Exact Sciences Corporation - Chairman of the Board, President & CEO

Thank you very much, Ivy. And Derik, if you're listening in, we wish you a speedy recovery. Thanks, everybody, for joining us today. It's really great to be invited back to the conference. We will be making forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot